ARCHIVES

Senate Finance Reports A Reform Bill On Deadline

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Cancer Meetings Listed

November 1, 1996